| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 24.708 | 36.423 | 42.583 | 39.483 | 36.775 | 1.901 | 0 |
| Total Income - EUR | - | - | - | 24.708 | 36.423 | 42.583 | 42.010 | 36.776 | 1.902 | 0 |
| Total Expenses - EUR | - | - | - | 14.011 | 15.265 | 16.948 | 20.110 | 15.055 | 6.991 | 0 |
| Gross Profit/Loss - EUR | - | - | - | 10.697 | 21.158 | 25.635 | 21.901 | 21.720 | -5.089 | 0 |
| Net Profit/Loss - EUR | - | - | - | 10.450 | 20.794 | 25.209 | 21.506 | 21.353 | -5.089 | 0 |
| Employees | - | - | - | 0 | 2 | 2 | 2 | 2 | 0 | 0 |
Check the financial reports for the company - P.alexandra Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | 11.922 | 32.320 | 34.961 | 37.406 | 54.179 | 2.884 | 2.868 |
| Inventories | - | - | - | 0 | 345 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 2.669 | 2.366 | 3.563 | 3.326 | 2.789 | 2.876 | 2.860 |
| Cash | - | - | - | 9.252 | 29.610 | 31.398 | 34.080 | 51.391 | 8 | 8 |
| Shareholders Funds | - | - | - | 10.493 | 31.084 | 26.760 | 35.546 | 52.953 | -2.041 | -2.059 |
| Social Capital | - | - | - | 43 | 42 | 41 | 42 | 43 | 42 | 42 |
| Debts | - | - | - | 1.429 | 1.236 | 8.201 | 1.860 | 1.227 | 4.925 | 4.928 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - P.alexandra Med S.r.l.